Iatrogenic Cushing’s Syndrome with Osteoporosis and Secondary Adrenal Failure in Human Immunodeficiency Virus-Infected Patients Receiving Inhaled Corticosteroids and Ritonavir-Boosted Protease Inhibitors: Six Cases
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Ritonavir, a protease inhibitor (PI), is a potent inhibitor of cytochrome P450 3A4. This pharmacological effect, even at low doses (≤200 mg/d), is used to “boost” levels of other PIs in the treatment of HIV infection and facilitate once or twice daily dosing with reduced pill burden. Six patients with preexisting HIV-lipodystrophy developed symptomatic Cushing’s syndrome when treated with inhaled fluticasone at varying doses for asthma while concurrently treated with low-dose ritonavir-boosted PI antiretroviral therapy (ART) regimens for HIV infection. There was evidence of adrenal suppression in all patients on stimulation studies. After the withdrawal of inhaled fluticasone, four patients became symptomatic of hypocortisolism, and three required oral corticosteroid support for several months. Other complications included evidence of osteoporosis (n = 3), crush fractures (n = 1), and exacerbation of preexisting type 2 diabetes mellitus (n = 1). In part, the diagnosis of fluticasone-induced Cushing’s syndrome was delayed because all patients had preexisting body composition changes of ART-associated lipodystrophy, masking the Cushing’s features. Practitioners should be aware of the impact on the adrenal axis of coadministration of PI-based ART regimens with inhaled corticosteroids and the potential for exacerbating or even inducing other metabolic conditions, such as osteoporosis or diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Schambelan, M., Benson, C. A., Carr, A., Currier, J. S., Dubé, M. P., Gerber, J. G., Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Mulligan, K., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200211010-00001 · Cited by 379
Research works printed but not linked: 14
- Dybul, 2002, Guidelines for using antiretroviral agents among HIV-infected adults and adolescents, Ann Intern Med, 137, 381, 10.7326/0003-4819-137-5_Part_2-200209031-00001 · DOI · Paper page
- Zeldin, 2004, Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients., Antimicrob Chemother, 53, 4, 10.1093/jac/dkh029 · DOI · Paper page
- Williams, 2003, National Asthma Education and Prevention Program. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program., MMWR Recomm Rep, 52, 1
- Mollmann, 1998, Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration., Eur J Clin Pharmacol, 53, 459, 10.1007/s002280050407 · DOI
- Chen, 1999, Cushing’s syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone., Sex Transm Infect, 75, 274
- Findlay, 1998, Lesson of the week: childhood Cushing’s syndrome induced by betamethasone nose drops and repeat prescriptions., BMJ, 317, 739, 10.1136/bmj.317.7160.739 · DOI · Paper page
- Mollmann, 2001, Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects., J Clin Pharmacol, 41, 1329, 10.1177/00912700122012913 · DOI
- Gupta, 2002, Exogenous Cushing syndrome mimicking human immunodeficiency virus lipodystrophy, Clin Infect Dis, 35, e69, 10.1086/342562 · DOI · Paper page
- Hillebrand-Haverkort, 1999, Ritonavir-induced Cushing’s syndrome in a patient treated with nasal fluticasone., AIDS, 13, 1803, 10.1097/00002030-199909100-00038 · DOI
- Rouanet, 2003, Cushing’s syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasone., HIV Med, 4, 149, 10.1046/j.1468-1293.2003.00149.x · DOI
- Clevenbergh, 2002, Iatrogenic Cushing’s syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen., J Infect, 44, 194, 10.1053/jinf.2001.0928 · DOI
- Kannisto, 2004, Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients., Eur J Endocrinol, 150, 687, 10.1530/eje.0.1500687 · DOI
- Ingelman-Sundberg, 2004, Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms., Naunyn Schmiedebergs Arch Pharmacol, 369, 89, 10.1007/s00210-003-0819-z · DOI · Paper page
- Wilson, 2000, Asthma and Cushing’s syndrome., Chest, 117, 593, 10.1378/chest.117.2.593 · DOI
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“depends on the potency of the preparation used, its dose, the route and duration of its administration, and whether concomitant medications prolong its half-life (27).”
BackgroundGlucocorticoid-Induced Bone Disease
Weinstein, R. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1012926 · Cited by 694
Foisy, M., Yakiwchuk, E., Chiu, I., & Singh, A. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00579.x · Cited by 174
Bone Disease and HIV Infection
Mayer, K. H., Amorosa, V., & Tebas, P. (2006) · Clinical Infectious Diseases · doi:10.1086/498511 · Cited by 158
Ahmet, A., Kim, H., & Spier, S. (2011) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-7-13 · Cited by 114
Metadata
- Authors
- Samaras, K., Pett, S., Gowers, A., McMurchie, M., & Cooper, D. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 4394-4398
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2077434641
- Cited by
- 133
- References
- 2
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.